Our services
Inherited cancer risk
Cancer in the family can cause great, and sometimes unnecessary, concern. iCellate analyzes the DNA in a simple saliva sample, assesses your hereditary risk for cancer, and suggests preventative action.
Inherited cancer risk
Those of you who have relatives affected by cancer may want to consider assessing your own risk of developing cancer. One third of the population is directly affected by cancer, and 5-10% of all cancers are hereditary. Understanding your hereditary risk can help you take preventative action. Hereditary risk can be determined through a genetic test, like GeneMate®. GeneMate® analyzes so-called genomic DNA (gDNA) that contains information about your hereditary risk.
GeneMate® sample collection occurs on your terms, in your home. A sample collection kit is delivered straight to your mailbox with instructions and materials for saliva collection, as well as everything you need to return the sample to iCellate's lab. iCellate performs a comprehensive analysis and breaks down complex information, ultimately providing you with a concrete risk assessment. iCellate's clinical team is available for consultation along the way.
Services include:
- Saliva DNA collection kit
- Genetic analysis of 41 genes
- Clinical report with cancer risk results
- Support from our licensed genetic counselors along the way
Genetic cancer evaluation
A genetic cancer evaluation is for those who have already been diagnosed with cancer. The public healthcare system follows established guidelines, while private alternatives may offer cutting edge technology early. iCellate has developed new methods, which likely will become standard of care in a few years.
A blood sample can show presence of tumor fragments (called ctDNA). The DNA fragments can be analyzed (sequenced). The resulting list of genetic defects presented in a clinical report may suggest individualized treatment options.
It is important that you as a patient and your doctor agree on which tests that will provide the desired information.
iCellate's expert is always available if you have a specific question about the test or the report.
Services include:
- Blood collection kit
- Genetic analysis of 36 genes*
- Clinical report with actionable results
Personal cancer screening
There is not yet a universal cancer-test in the public healthcare system for finding cancer early, i.e. screening. The tests that are available, such as mammography (for breast cancer) and PSA (for prostate cancer), are only focused on one type of cancer and the benefit is therefore limited.
iCellate has demonstrated through two major scientific studies (see here) that our technology serves well as a screening tool.
If you choose to take iCellate’s Personal cancer screening test, you should familiarize yourself with the implications. What does a positive test result (with traces of cancer in the blood) mean for you? Read more under the FAQs.